Autolus Therapeutics (AUTL)

• Market cap: $391M
• 1 day: -5.77%
• 5 days: -2.65%
• 1 month: 6.52%
• 3 months: -8.7%
• 6 months: 6.52%
• Year to date: -21.39%
• 1 year: -25.76%
• 5 years: -78.06%
• 10 years: -94.12%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647